Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release -- a feasibility study using bisphosphonates

References

• AKBUGA, J. and DURMAZ, G., 1994, Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. International Journal of Pharmaceutics, 111, 217–222.
   Google Scholar
• BODMER, D., KISSEL, T. and TRAECHSLIN, E., 1992, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. Journal of Controlled Release, 21, 129–138.
   Web of Science ®Google Scholar
• BRICH, Z. and KISSEL, T., 1983, Polyolester, deren Herstellung und Verwendung. Swiss Patent Application, # 656 884 A5.
   Google Scholar
• FILIPOVIC-GRCIC, J., BECIREVIC-LACAN, M., SKALKO, N. and JALSENJAK, I., 1996, Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. International Journal of Pharmaceutics, 135, 183–190.
   Google Scholar
• FLESCH, G. and HAUFFE, S. A., 1989, Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection. Journal of Chromatography, 489, 446–451.
   PubMedGoogle Scholar
• FLESCH, G., TOMINAGA, N. and DEGEN, P., 1991, Improved determination of the bisphosphonate pamidronate disodium in plasma and urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection. Journal of Chromatography, 568, 261–266.
   PubMedGoogle Scholar
• GoLoms, G., DIXON, M., SMITH, M., SCHOEN, F. J. and LEVY, R. J., 1987, Controlled-release drug delivery of diphosphonates to inhibition bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating. Journal of Pharmaceutical Science, 76, 271–276.
   PubMedGoogle Scholar
• HE, P., DAVIS, S. S. and ILLum, L., 1999, Chitosan microspheres prepared by spray drying. International Journal of Pharmaceutics, 187, 53–65.
   PubMedGoogle Scholar
• JoNEs, D. H., CORRIES, S., MCDONALD, S., CLEGG, J. C. S. and FARRAR, G. H., 1997, Poly(DL-lactide-co-glycolide) encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine, 15, 814–817.
   Google Scholar
• KAETSU, I., YOSHIDA, M., ASANO, M., YAMANAKA, H., Imm, K., YUASA, H., MASHIMO, T., SuzuK), K., KATAKAI, R. and OYA, M., 1987, Biodegradable implant composition for local therapy. Journal of Controlled Release, 6, 249–263.
   Google Scholar
• KISSEL, T., 1983, Injizierbare Retardformen. Acta Pharmaceutica Technologica, 29, 221–239.
   Google Scholar
• KISSEL, T., BRICH, Z., BANTLE, S., LANCRANJAN, I., NIMMERFALL, F. and VIT, P., 1991, Parenteral depot-systems on the basis of biodegradable polyesters. Journal of Controlled Release, 16, 27–42.
   Web of Science ®Google Scholar
• KISSEL, T., KONEBERG, R., HILBERT, A. K. and HUNGERER, K. D., 1997, Microencapsulation of antigens using biodegradable polyesters: facts and fantasies. Behring Institute Mitteilungen, 98, 172–183.
   Google Scholar
• LEWIS, D. H., 1990, Controlled release of bioactive agents from lactide/glycolide polymers. Biodegradable Polymers as Drug Delivery Systems, edited by M. Chasin and R. Langer (New York: Marcel Dekker), pp. 1–41.
   Google Scholar
• MOHR, D, 1997, Untersuchung zur Mikroverkapselung lipophiler Wirkstoffe mit Hilfe bioabbaubarer Polymere am Beispiel von 17 beta-Estradiol. PhD thesis, University of Marburg.
   Google Scholar
• PATASHNIK, S., RABINOVICH, L. and GoLoms, G., 1997, Preparation and evaluation of chitosan microspheres containing bisphosphonates. Journal of Drug Targeting, 4, 371–380.
   PubMedGoogle Scholar
• PISTEL, K. F., BITTNER, B., KOLL, H., WINTER, G. and KISSEL, T., 1999, Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. Journal of Controlled Release, 59, 309–325.
   PubMedGoogle Scholar
• RUSSELL, R. G. G., CROUCHER, P. I. and ROGERS, M. J., 1999, Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporosis International Supplement, 2, S66–S80.
   Google Scholar
• SANDERS, L. M., KELL, B. A., McRAE, G. I. and WHITEHEAD, G. W., 1986, Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. Journal of Pharmaceutical Science, 75, 356–360.
   PubMedGoogle Scholar
• SIEGEL, R. A. and LANGER, R., 1984, Controlled release of polypeptides and other macromolecules. Pharmaceutical Research, 1, 2–10.
   PubMedGoogle Scholar
• VASUDEV, S. C., CHANDY, T. and SHARMA, C. P., 1997, Development of chitosan/ polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis. Biomaterials, 18, 375–381.
   PubMedGoogle Scholar
• WEIDENAUER, U., 2000, Feasibility study for the microencapsulation of pamidronate-disodium using D,L-poly(lactide-co-glycolide acid-glucose): evaluation of different techniques and devices. PhD thesis, University of Marburg.
   Google Scholar
• WEIDENAUER, U., BODMER, D. and KISSEL, T., 2003, Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: Evaluation of different techniques for the encapsulation of pamidronate di-sodium salt. Journal of Microencapsulation, 20, 509–524.
   PubMedGoogle Scholar
• WITT, C., MAEDER, K. and KISSEL, T., 2000, The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression molding of poly(lactide-co-glycolide) and ABA triblock copolymers. Biomaterials, 21, 931–938.
   PubMedGoogle Scholar
• YAMAKAWA, I., KAWAHARA, M., WATANABE, S. and MIYAKE, Y., 1990, Sustained release of insulin by double-layered implant using poly(D,L-lactic acid). Journal of Pharmaceutical Science, 79, 505–509.
   PubMedGoogle Scholar